---
title: "TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287275847.md"
description: "TherapeuticsMD Inc. (TXMD) shares rose 1.44% to $2.11 on a positive trading day, marking the fifth consecutive day of gains. The stock remains 28.47% below its 52-week high of $2.95. In comparison, AbbVie Inc. (ABBV) increased by 1.04% to $214.50. Trading volume was below the 50-day average."
datetime: "2026-05-21T21:33:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287275847.md)
  - [en](https://longbridge.com/en/news/287275847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287275847.md)
---

# TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) rose 1.44% to $2.11 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.09% to 26,293.10 and the Dow Jones Industrial Average rising 0.55% to 50,285.66.

This was the stock's fifth consecutive day of gains.

TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company achieved on January 27th.

The stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) rose 1.04% to $214.50.

Trading volume (12,896) remained 8,571 below its 50-day average volume of 21,467.

Data source: Dow Jones Market Data, FactSet. Data compiled May 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-21-26 1733ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [TherapeuticsMD Explains Brief Delay In Annual Filing](https://longbridge.com/en/news/281395694.md)
- [Medicenna to Showcase First-in-Class Tumor-Targeted PD-1 x IL-2 Superkine at AACR 2026](https://longbridge.com/en/news/279598836.md)
- [TherapeuticsMD swings to Q1 net income as license revenue rises](https://longbridge.com/en/news/286150322.md)
- [Synergy Empire Ltd 1Q 2025: Revenue $12.5K, EPS $(0.01) — 10-Q Summary](https://longbridge.com/en/news/284793355.md)
- [Health Care Up on Rotation Into Laggards — Health Care Roundup](https://longbridge.com/en/news/288908897.md)